CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY)
Historical Holders from Q1 2017 to Q4 2025
-
Type / Class
-
Equity / ADR
-
Symbol
-
CHGCY
-
Price per share
-
$26.27
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
140,494
-
Total reported value
-
$3,094,381
-
% of total 13F portfolios
-
0%
-
Share change
-
-37,040
-
Value change
-
-$860,539
-
Number of holders
-
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025,
CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY) has
8
institutional shareholders
filing 13F forms.
They hold
140,494 shares.
.
Institutional Holders of CHUGAI PHARMACEUTICAL CO LTD ADR - ADR (CHGCY) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q4
|
58,014
|
$1,524,028
|
+$103,793
|
|
|
$26.27
|
2
|
|
2025 Q3
|
140,494
|
$3,094,381
|
-$860,539
|
|
|
$22.11
|
8
|
|
2025 Q2
|
177,534
|
$4,626,291
|
+$61,685
|
|
|
$26.07
|
12
|
|
2025 Q1
|
175,170
|
$3,983,186
|
+$404,396
|
|
|
$22.74
|
11
|
|
2024 Q4
|
157,400
|
$3,478,355
|
-$359,565
|
|
|
$21.97
|
7
|
|
2024 Q3
|
172,761
|
$4,171,984
|
-$3,911,046
|
|
|
$24.09
|
8
|
|
2024 Q2
|
323,971
|
$5,756,959
|
+$525,079
|
|
|
$17.77
|
6
|
|
2024 Q1
|
293,340
|
$5,611,597
|
+$200,772
|
|
|
$19.13
|
9
|
|
2023 Q4
|
282,883
|
$5,326,910
|
-$320,150
|
|
|
$18.85
|
8
|
|
2023 Q3
|
294,427
|
$4,531,526
|
-$292,856
|
|
|
$15.39
|
6
|
|
2023 Q2
|
313,684
|
$4,464,886
|
-$3,136,053
|
|
|
$14.19
|
6
|
|
2023 Q1
|
571,378
|
$7,017,491
|
+$1,297,009
|
|
|
$12.28
|
6
|
|
2022 Q4
|
465,771
|
$5,902,444
|
+$2,700,575
|
|
|
$12.67
|
4
|
|
2022 Q3
|
252,565
|
$3,143,000
|
-$4,016,914
|
|
|
$12.49
|
3
|
|
2022 Q2
|
286,130
|
$3,654,000
|
+$375,043
|
|
|
$12.77
|
3
|
|
2022 Q1
|
472,077
|
$7,870,000
|
+$875,315
|
|
|
$16.69
|
4
|
|
2021 Q4
|
419,559
|
$6,860,000
|
-$1,463,764
|
|
|
$16.35
|
4
|
|
2021 Q3
|
484,112
|
$8,889,000
|
+$4,881,258
|
|
|
$18.36
|
9
|
|
2021 Q2
|
218,255
|
$4,343,000
|
-$26,864,300
|
|
|
$19.91
|
5
|
|
2021 Q1
|
1,541,688
|
$31,294,011
|
-$5,652,923
|
|
|
$20.29
|
9
|
|
2020 Q4
|
1,738,494
|
$46,266,416
|
+$4,305,261
|
|
|
$26.60
|
10
|
|
2020 Q3
|
1,576,618
|
$35,290,824
|
+$32,279,028
|
|
|
$22.40
|
9
|
|
2020 Q2
|
125,955
|
$41,101,157
|
+$10,874,947
|
|
|
$326.09
|
9
|
|
2020 Q1
|
92,691
|
$21,268,371
|
-$6,868,303
|
|
|
$227.69
|
8
|
|
2019 Q4
|
122,550
|
$22,731,723
|
-$22,365
|
|
|
$185.44
|
8
|
|
2019 Q3
|
123,103
|
$19,117,382
|
+$16,192,622
|
|
|
$154.90
|
8
|
|
2019 Q2
|
18,871
|
$2,483,000
|
+$1,127,519
|
|
|
$130.47
|
5
|
|
2019 Q1
|
10,327
|
$1,425,000
|
+$848,177
|
|
|
$137.96
|
4
|
|
2018 Q4
|
3,621
|
$420,000
|
-$22,154
|
|
|
$115.99
|
1
|
|
2018 Q3
|
3,812
|
$397,000
|
-$7,186
|
|
|
$104.14
|
1
|
|
2018 Q2
|
3,881
|
$435,000
|
-$30,375
|
|
|
$112.08
|
1
|
|
2018 Q1
|
4,152
|
$428,000
|
-$22,987
|
|
|
$103.08
|
1
|
|
2017 Q4
|
4,375
|
$447,000
|
-$25,645
|
|
|
$102.17
|
1
|
|
2017 Q3
|
4,626
|
$381,000
|
+$5,106
|
|
|
$82.36
|
1
|
|
2017 Q2
|
4,564
|
$351,000
|
-$12,459
|
|
|
$76.91
|
1
|
|
2017 Q1
|
4,726
|
$332,000
|
+$332,000
|
|
|
$70.25
|
1
|